Newsfeeds - Spark Newswire

1 minute read

PepGen’s Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta’s Candidate, Says Analyst

Today, 12:43 PM

PepGen Inc (NASDAQ:PEPG) reported data from PGN-EDO51’s SAD study in adult healthy volunteers that suggest best-in-class exon skipping capabilities. SVB notes…

PEPG

4 minute read

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 12:43 PM

Gainers

ABOS

3 minute read

Dow Jumps 300 Points; Crude Oil Rises Sharply

By Lisa Levin

Today, 12:43 PM

U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Wednesday.

ABOS

4 minute read

PepGen Reports Data From Phase 1 Trial Of PGN-EDO51 For Treatment Of Duchenne Muscular Dystrophy

By Bill Haddad

Today, 12:43 PM

PGN-EDO51 exhibited the highest levels of oligonucleotide delivery and exon skipping in a clinical study following a single dose when compared to publicly available clinical data for other exon 51 skipping

PEPG

19 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 12:43 PM

On Wednesday, 340 stocks hit new 52-week lows.

$APE

24 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 12:43 PM

On Monday, 429 stocks made new 52-week lows.

ADCT

5 minute read

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday

By Lisa Levin

Today, 12:43 PM

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

AAOI

29 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 12:43 PM

During Friday's session, 574 stocks hit new 52-week lows.

ACCO

5 minute read

Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday

By Lisa Levin

Today, 12:43 PM

Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.

1 minute read

PepGen Q2 EPS $(1.23)

By Bill Haddad

Today, 12:43 PM

PepGen (NASDAQ:PEPG) reported quarterly losses of $(1.23) per share.

PEPG